Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor– Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results

Post time 2022-7-2 10:48:46

journal：Canadian Journal of Hospital Pharmacy

Authors：Cristina Fernández-Cuerva; Juan Carlos Del Rio Valencia; Rocio Tamayo Bermejo

Published date：--

DOI：10.4212/cjhp.v75i1.3252

Article link：http://dx.doi.org/10.4212/cjhp.v75i1.3252

Article Source：Canadian Society of Hospital Pharmacists (CSHP)。

Remark：

Post time 2022-7-2 10:48:47

Please adopt

Post time 2022-7-3 06:13:36

imation replied at 2022-7-2 10:48
Please adopt

THANK YOU

[Other] Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor– Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results

Best Answer

Reply

Same Category

Latest Reply

Announcement

Enthusiastic users today

[Other] Effectiveness and Safety of Palbociclib plus Endocrine Therapy in Hormone Receptor– Positive, HER2-Negative Metastatic Breast Cancer: Real-World Results Copy